Prospective registry of pediatric cellular therapy patients at risk for endothelial dysfunction, sinusoidal obstruction syndrome and/or multi-organ dysfunction syndrome(POEM): pmods as a screening tool for endotheliopathies and critical care admission risk in pediatric HCT patients.
Shaikha Alqahtani(Duke University), Kris M. Mahadeo(Duke University), Keri Schadler(The University of Texas MD Anderson Cancer Center), Irtiza Sheikh(The University of Texas MD Anderson Cancer Center), Sangeeta Hingorani(University of Washington), Mira A. Kohorst(Mayo Clinic), Paibel Aguayo‐Hiraldo(Children's Hospital of Los Angeles), Basirat Shoberu(Albert Einstein College of Medicine), Hisham Abdel‐Azim(University of Southern California), Saleh Bhar(Baylor College of Medicine), Dristhi Ragoonanan(The University of Texas MD Anderson Cancer Center), L. D. Spencer(Duke University), Anant Vatsayan(Children's National), Jennifer McArthur(St. Jude Children's Research Hospital), Rajinder Bajwa(Nationwide Children's Hospital)
Cited by 0
Related Papers
Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae
|Journal of Clinical Microbiology|2018|775
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
|Blood|2016|333
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
|Nature Reviews Clinical Oncology|2018|237